No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AbbVie Announces Leadership Change With New Appointment
AbbVie: David R. Purdue Will Be Senior Vice President, Controller
AbbVie: Kevin K. Buckbee, Senior Vice President, Controller, Plans to Retire From Controller Role Effective March 1
This Drugmaker's (ABBV) Parkinson's Medication Just Cleared A Key Hurdle – Is It Primed For A Monster Year In 2025?
AbbVie to Buy Nimble Therapeutics
AbbVie: Nimble Shareholders Eligible for Potential Development Milestone Payment >ABBV